View Document Preview and Link Document Date: 2012-12-20 10:18:34 Open Document File Size: 80,53 KB Share Result on Facebook
City Vancouver / Cambridge / Fremont / Charlestown / / Company Imutran Ltd / Novartis Pharma (Basel Switzerland) SangStat Medical Corp. / Needham / Stem Cells Inc. / xenoNATURE BIOTECHNOLOGY / Novartis Pharma / Nature America Inc. / Company Program Alexion Pharmaceuticals / Chromos Molecular Systems / United States Surgical Corp. / Genzyme / / Continent North America / / Country Japan / United States / Canada / United Kingdom / / Currency USD / / Event M&A / Business Partnership / / IndustryTerm encapsulation technology / biotechnology / poor immunosuppression protocols / pharmaceutical / / MedicalCondition chronic pain control / xenotransplantation Chronic / disease / currently intractable degenerative disorders / novel infections / novel infections infections / intractable epilepsy / Huntington’s disease / diabetes / Parkinson’s disease / AIDS / infection / brain death / organ diseases / infections / neurodegenerative disorders / / MedicalTreatment gene therapy / immunosuppression / kidney transplants / hemodialysis / organ transplants / / Organization Advisory Committee of the National / / Person Deacon / / Product tral / / ProvinceOrState British Columbia / / PublishedMedium the National / / Technology gene therapy / genetic engineering / antibodies / biotechnology / transplantation / relatively poor immunosuppression protocols / encapsulation technology / / URL www.biovista.com / http / SocialTag 
© 2000 Nature America Inc. • http://biotech.nature.com TECHNOLOGIES Xenotransplantation